+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling

Plos One 9(2): E89016-E89016

RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling

Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accumulation of MRTF-A is inhibited. However, the molecular target of this inhibitor has not yet been identified. In this study, we investigated the mechanism of this effect of CCG-1423. The interaction between MRTF-A and importin α/β1 was inhibited by CCG-1423, but monomeric G-actin binding to MRTF-A was not inhibited. We coupled Sepharose with CCG-1423 (CCG-1423 Sepharose) to investigate this mechanism. A pull-down assay using CCG-1423 Sepharose revealed the direct binding of CCG-1423 to MRTF-A. Furthermore, we found that the N-terminal basic domain (NB) of MRTF-A, which acts as a functional nuclear localization signal (NLS) of MRTF-A, was the binding site for CCG-1423. G-actin did not bind to CCG-1423 Sepharose, but the interaction between MRTF-A and CCG-1423 Sepharose was reduced in the presence of G-actin. We attribute this result to the high binding affinity of MRTF-A for G-actin and the proximity of NB to G-actin-binding sites (RPEL motifs). Therefore, when MRTF-A forms a complex with G-actin, the binding of CCG-1423 to NB is expected to be blocked. NF-E2 related factor 2, which contains three distinct basic amino acid-rich NLSs, did not bind to CCG-1423 Sepharose, but other RPEL-containing proteins such as MRTF-B, myocardin, and Phactr1 bound to CCG-1423 Sepharose. These results suggest that the specific binding of CCG-1423 to the NLSs of RPEL-containing proteins. Our proposal to explain the inhibitory action of CCG-1423 is as follows: When the G-actin pool is depleted, CCG-1423 binds specifically to the NLS of MRTF-A/B and prevents the interaction between MRTF-A/B and importin α/β1, resulting in inhibition of the nuclear import of MRTF-A/B.

Accession: 055338577

PMID: 24558465

DOI: 10.1371/journal.pone.0089016

Related references

Bell, J.L.; Haak, A.J.; Wade, S.M.; Sun, Y.; Neubig, R.R.; Larsen, S.D., 2013: Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathway. CCG-1423 and related analogues represent a new class of inhibitors of Rho/MKL1/SRF-mediated gene transcription, a pathway that has been implicated in both cancer and fibrosis. The molecular target for these compounds is unknown. To facilitate its...

Mouilleron, S.; Wiezlak, M.; O'Reilly, N.; Treisman, R.; McDonald, N.Q., 2013: Structures of the Phactr1 RPEL domain and RPEL motif complexes with G-actin reveal the molecular basis for actin binding cooperativity. The Phactr family of PP1-binding proteins and the myocardin-related transcription factor family of transcriptional coactivators contain regulatory domains comprising three copies of the RPEL motif, a G-actin binding element. We report the structur...

Evelyn, C.R.; Wade, S.M.; Wang, Q.; Wu, M.; Iñiguez-Lluhí, J.A.; Merajver, S.D.; Neubig, R.R., 2007: CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Lysophosphatidic acid receptors stimulate a G alpha(12/13)/RhoA-dependent gene transcription program involving the serum response factor (SRF) and its coactivator and oncogene, megakaryoblastic leukemia 1 (MKL1). Inhibitors of this pathway could...

de Almagro, M.C.; Vucic, D., 2013: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Cell death regulation is vital for maintenance of homeostasis and proper development of multicellular organisms. Inhibitor of apoptosis (IAP) proteins are implicated in multiple ways in cell death regulation, ranging from inhibition of apoptosis a...

Herzig, S.; Knepel, W., 1998: Molecular cloning of pancreatic islet winged helix proteins Candidates for targets of insulin signaling. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4 SUPPL): R83

Lu, W.Jing.; Lee, N.P.; Fatima, S.; Luk, J.M., 2009: Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Heat shock proteins (HSPs) consist of a large group of proteins with negligible expressions under physiological conditions. Their expressions are highly induced under stress conditions and they are ubiquitously expressed in various tissues and org...

Guettler, S.; Vartiainen, M.K.; Miralles, F.; Larijani, B.; Treisman, R., 2007: RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Myocardin (MC) family proteins are transcriptional coactivators for serum response factor (SRF). Each family member possesses a conserved N-terminal region containing three RPEL motifs (the "RPEL domain"). MAL MKL1/myocardin-related tran...

Favot, L.; Gillingwater, M.; Scott, C.; Kemp, P.R., 2004: Overexpression of a family of RPEL proteins modifies cell shape. Proteins containing RPEL motifs (e.g., MAL) are important in the regulation of gene expression by the actin cytoskeleton. Screening the ENSEMBL database for RPEL proteins identified four additional proteins that contain RPEL motifs and nuclear loc...

Cimoli, G.; Bagnasco, L.; Pescarolo, M.P.; Avignolo, C.; Melchiori, A.; Pasa, S.; Biasotti, B.; Taningher, M.; Parodi, S., 2002: Signaling proteins as innovative targets for antineoplastic therapy: our experience with the signaling protein c-myc. Tumori 87(6): S20-S23

Tabuchi, A., 2006: RPEL family proteins: transcriptional co-activators and mediators for actin-based structural alteration. Seikagaku. Journal of Japanese Biochemical Society 78(10): 987-997